• Chemotherapy-Induced Peripheral Neuropathy Market Expected to Reach $1.67 Billion by 2034
    The chemotherapy-induced peripheral neuropathy market is gaining significant attention due to the rising number of cancer patients undergoing chemotherapy worldwide. Chemotherapy treatments, while effective against cancer, often cause nerve damage leading to peripheral neuropathy. This condition creates a growing demand for effective treatment solutions and supportive therapies, thereby driving...
    0 Comments 0 Shares 478 Views 0 Reviews